LUNG GROWTH AT HIGH ALTITUDE AND MAXIMAL O2 TRANSPORT

高海拔和最大氧气输送下的肺生长

基本信息

  • 批准号:
    6875029
  • 负责人:
  • 金额:
    $ 37.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-06-01 至 2007-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Applicant's abstract): Human natives of high altitude (HA) develop increased lung volume and diffusing capacity consistent with enhanced alveolar growth, and increase blood volumes that facilitate 02 transport. However, other adaptation to HA (muscularization of pulmonary arterioles, dysanaptic airway growth and retardation of thoracic growth) may impair O2 transport. The interplay among these factors at different altitudes is not known. Functional consequences of these structural changes can be isolated only after re-acclimatization to sea level (SL) when reversible changes in blood volume and pulmonary vascular reactivity have subsided. We employ this approach to address long-term structure-function relationships of maturation at HA in dogs. Hypotheses are 1) Hypoxia stimulates alveolar hyperplasia and enhances diffusive gas exchange. 2) Airway growth lags behind alveolar growth at HA, leading to uneven distribution of ventilation and increased ventilatory work. 3) Pulmonary vascular changes at HA significantly limits maximal cardiac output at SL. 4) Structural changes at HA persist after reacclimatization to SL and exert opposing effects on O2 transport, i.e., persistent vascular and airway abnormalities offset benefits derived from enhanced alveolar growth. 5) Growth of thorax is impaired in an altitude-dependent way; at extreme altitude, the restricted thoracic size sets an upper limit to lung growth and O2 transport. We plan to raise immature dogs (age 2 mo.) to somatic maturity (12 mo.) at 3 levels of HA (3, 100m, 3,800m or 4,500m in separate groups) compared with controls raised at SL. Dogs will be returned to SL at maturity for cardiopulmonary testing at rest and exercise, including pressure-volume curves, maximal 02 uptake, efficiency of gas exchange and diffusing capacity of lungs (DL) and muscles, ventilatory work, hemodynamics and blood volume. Dimensions of airways, diaphragm, rib cage, lungs and spleen will be assessed by spiral CT scan. Components of DL, septal tissue volume and pulmonary blood flow will be measured at regular intervals and correlated with blood volume. After 1 yr. of re-acclimatization to SL, studies will be repeated to determine regression of changes. Terminally, detailed structural analysis will be performed on the lungs, respiratory, locomotive and ventricular muscles, as well as ribs and long bones. Growth patterns of the acini, airways, vasculature, thoracic structures and their functional correlates will be compared at the 3 levels of hypoxia to determine the altitude-dependence of adaptation in O2 transport.
描述(申请人摘要):人类在高海拔地区(HA)发展 肺容量和弥散能力的增加与肺泡的增强一致 生长,并增加血液容量,促进02的运输。然而,其他 对HA(肺小动脉肌化、呼吸紊乱)的适应 生长和胸部发育迟缓)可能会损害氧气的运输。这个 这些因素在不同海拔之间的相互作用尚不清楚。功能性 这些结构性变化的后果只有在以下情况下才能被隔离 当血容量发生可逆变化时重新适应海平面(SL) 肺血管反应性减弱。我们采用这种方法来 解决狗的HA成熟的长期结构-功能关系。 假设1)低氧刺激肺泡增生并增强 扩散性气体交换。2)HA的气道生长滞后于肺泡的生长, 导致通风分配不均,增加通风功。 3)HA时肺血管改变明显限制最大心输出量 在SL。4)HA的结构变化在重新适应SL和 对氧气运输产生相反的影响,即持续的血管和呼吸道 异常抵消了促进肺泡生长所带来的好处。5)增长 胸腔的高度依赖于高度而受损;在极端海拔, 胸围限制对肺生长和氧气运输设定了上限。 我们计划饲养未成熟的狗(2个月大)至体细胞成熟(12mo.)在3点 透明质酸水平(分别为3、100、3,800或4,500米)与 在SL处引发的控件。成年后,狗只将被送回SL,用于 休息和运动时的心肺测试,包括压力-容量曲线, 最大吸氧量、气体交换效率和肺弥散能力 (Dl)和肌肉、呼吸功、血流动力学和血量。尺寸 用螺旋CT对呼吸道、横隔膜、胸腔、肺和脾进行检查 扫描。DL的成分、间隔组织体积和肺血流量将 每隔一定时间测量一次,并与血容量相关。一年后。的 重新适应SL,将重复研究以确定回归 改变。最后,详细的结构分析将在 肺、呼吸肌、运动肌和心室肌,以及肋骨和 很长的骨头。腺泡、呼吸道、血管、胸腺的生长模式 结构和它们的功能相关性将在三个水平上进行比较 低氧以确定氧气运输中适应的海拔依赖性。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Southwestern Internal Medicine Conference: pulmonary complications of high-altitude exposure.
西南内科会议:高原暴露肺部并发症。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT LEE JOHNSON其他文献

ROBERT LEE JOHNSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT LEE JOHNSON', 18)}}的其他基金

HEMATOCRIT & BLOOD VOLUME--EFFECTS OF MAXIMAL 02 INTAKE
分血器
  • 批准号:
    2232262
  • 财政年份:
    1996
  • 资助金额:
    $ 37.21万
  • 项目类别:
LUNG GROWTH AT HIGH ALTITUDE AND MAXIMAL O2 TRANSPORT
高海拔和最大氧气输送下的肺生长
  • 批准号:
    6726052
  • 财政年份:
    1996
  • 资助金额:
    $ 37.21万
  • 项目类别:
HEMATOCRIT & BLOOD VOLUME--EFFECTS OF MAXIMAL 02 INTAKE
分血器
  • 批准号:
    2430783
  • 财政年份:
    1996
  • 资助金额:
    $ 37.21万
  • 项目类别:
HEMATOCRIT & BLOOD VOLUME--EFFECTS OF MAXIMAL 02 INTAKE
分血器
  • 批准号:
    6017277
  • 财政年份:
    1996
  • 资助金额:
    $ 37.21万
  • 项目类别:
LUNG GROWTH AT HIGH ALTITUDE AND MAXIMAL O2 TRANSPORT
高海拔和最大氧气输送下的肺生长
  • 批准号:
    6287953
  • 财政年份:
    1996
  • 资助金额:
    $ 37.21万
  • 项目类别:
LUNG GROWTH AT HIGH ALTITUDE AND MAXIMAL O2 TRANSPORT
高海拔和最大氧气输送下的肺生长
  • 批准号:
    6537167
  • 财政年份:
    1996
  • 资助金额:
    $ 37.21万
  • 项目类别:
HEMATOCRIT & BLOOD VOLUME--EFFECTS OF MAXIMAL 02 INTAKE
分血器
  • 批准号:
    2714088
  • 财政年份:
    1996
  • 资助金额:
    $ 37.21万
  • 项目类别:
LUNG GROWTH AT HIGH ALTITUDE AND MAXIMAL O2 TRANSPORT
高海拔和最大氧气输送下的肺生长
  • 批准号:
    6638403
  • 财政年份:
    1996
  • 资助金额:
    $ 37.21万
  • 项目类别:
LIMITATION TO EXERCISE AFTER PNEUMONECTOMY
肺切除术后限制运动
  • 批准号:
    2219482
  • 财政年份:
    1988
  • 资助金额:
    $ 37.21万
  • 项目类别:
LIMITATION TO EXERCISE AFTER PNEUMONECTOMY
肺切除术后限制运动
  • 批准号:
    2430671
  • 财政年份:
    1988
  • 资助金额:
    $ 37.21万
  • 项目类别:

相似海外基金

Implication search for peripheral blood circulation cancer cellsas a Liquid biopsy target
外周血循环癌细胞作为液体活检目标的意义研究
  • 批准号:
    21H03021
  • 财政年份:
    2021
  • 资助金额:
    $ 37.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Feasibility study to reach 'market readiness' with Recocoa's unique cacao based health bar, which is the only health nutrition bar which meets the European Health Claim (EFSA) in improving blood circulation by maintaining the elasticity of blood vessels.
Recocoa 独特的可可健康棒进行了“市场准备”的可行性研究,该健康棒是唯一符合欧洲健康声明 (EFSA) 通过保持血管弹性改善血液循环的健康营养棒。
  • 批准号:
    106360
  • 财政年份:
    2020
  • 资助金额:
    $ 37.21万
  • 项目类别:
    Collaborative R&D
Feasibility study to reach 'market readiness' with Recocoa's unique cacao based health bar, which is the only health nutrition bar which meets the European Health Claim (EFSA) in improving blood circulation by maintaining the elasticity of blood vessels.
Recocoa 独特的可可健康棒进行了“市场准备”的可行性研究,该健康棒是唯一符合欧洲健康声明 (EFSA) 通过保持血管弹性改善血液循环的健康营养棒。
  • 批准号:
    72375
  • 财政年份:
    2020
  • 资助金额:
    $ 37.21万
  • 项目类别:
    Feasibility Studies
Quantitative evaluation of blood circulation by deep learning in short time DCE-MRI
短时间深度学习DCE-MRI对血液循环的定量评估
  • 批准号:
    20K08041
  • 财政年份:
    2020
  • 资助金额:
    $ 37.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Evaluation of the micro blood circulation of the oral free flaps by indocyanin green near-infrared fluorescence angiography
吲哚青绿近红外荧光血管造影评价口腔游离皮瓣的微血循环
  • 批准号:
    19K10299
  • 财政年份:
    2019
  • 资助金额:
    $ 37.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a new treatment for pancreatic cancer by controlling immune response avoidance of blood circulation cancer stem cells
通过控制血液循环癌症干细胞的免疫反应避免建立胰腺癌新疗法
  • 批准号:
    19K09139
  • 财政年份:
    2019
  • 资助金额:
    $ 37.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of ICG fluorescence contrast imaging analysis system specialized for evaluation of peripheral tissue blood circulation
开发专门评估末梢组织血液循环的ICG荧光对比成像分析系统
  • 批准号:
    19K18925
  • 财政年份:
    2019
  • 资助金额:
    $ 37.21万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Hemopurifier Device for Targeted Removal of Breast Cancer Exosomes from the Blood Circulation
用于从血液循环中靶向去除乳腺癌外泌体的血液净化器装置
  • 批准号:
    9620493
  • 财政年份:
    2018
  • 资助金额:
    $ 37.21万
  • 项目类别:
Development of the small blood circulation simulator to deepen the non-clinical evaluation of medical devices
开发小型血液循环模拟器深化医疗器械非临床评价
  • 批准号:
    18H03555
  • 财政年份:
    2018
  • 资助金额:
    $ 37.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Experimental analysis of conservative therapy for blood circulation disorders using multifaceted optical measurement of nerve activity and peripheral blood flow
多层面光学测量神经活动和外周血流量保守治疗血液循环障碍的实验分析
  • 批准号:
    17K10764
  • 财政年份:
    2017
  • 资助金额:
    $ 37.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了